We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.49B
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+5.69%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.59%
5 Year Est. Return
+121.06%
10 Year Est. Return
+327.09%
AUM
$5.82B
AUM Growth
-$977M
Cap. Flow
-$270M
Cap. Flow %
-4.64%
Top 10 Hldgs %
38.85%
Holding
370
New
37
Increased
64
Reduced
141
Closed
67

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$98.8M
2
PRMW
Primo Water Corporation
PRMW
+$73.5M
3
ATH
Athene Holding Ltd. Class A Common Shares
ATH
+$66.3M
4
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$62.1M
5
MCD icon
McDonald's
MCD
+$58.1M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$162M
2
GLW icon
Corning
GLW
+$122M
3
PF
Pinnacle Foods, Inc.
PF
+$67.6M
4
MPG
Metaldyne Performance Group Inc.
MPG
+$59.7M
5
AMAT icon
Applied Materials
AMAT
+$57.5M

Sector Composition

Rank Sector Weight
1 Financials 22.68%
2 Technology 15.88%
3 Healthcare 14.26%
4 Consumer Staples 9.97%
5 Energy 9.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATH
26
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$68.8M 1.18%
+1,433,996
New +$66.3M
SUM
27
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$68.3M 1.17%
+2,961,491
New +$62.1M
MCRN
28
DELISTED
Milacron Holdings Corp.
MCRN
$65.4M 1.12%
3,512,076
+223,972
+7% +$3.66M
KKR icon
29
KKR & Co
KKR
$89.8B
$62.9M 1.08%
4,085,516
-265,848
-6% -$4.01M
VZ icon
30
Verizon
VZ
$214B
$59.5M 1.02%
1,114,934
+11,525
+1% +$576K
ZBH icon
31
Zimmer Biomet
ZBH
$18.8B
$57.4M 0.99%
572,717
+169,056
+42% +$18.1M
MSFT icon
32
Microsoft
MSFT
$3.69T
$52.8M 0.91%
849,839
-56,440
-6% -$3.39M
JNJ icon
33
Johnson & Johnson
JNJ
$644B
$50.7M 0.87%
439,808
-36,941
-8% -$4.27M
GLW icon
34
Corning
GLW
$124B
$50.3M 0.86%
2,072,771
-5,124,121
-71% -$122M
BIO icon
35
Bio-Rad Laboratories Class A
BIO
$10.1B
$48.8M 0.84%
267,619
-110,893
-29% -$18.9M
VOYA icon
36
Voya Financial
VOYA
$9.28B
$47.7M 0.82%
1,216,122
+874,072
+256% +$30.8M
ATKR icon
37
Atkore
ATKR
$3.19B
$45.8M 0.79%
1,916,778
-348,263
-15% -$7.16M
LAB icon
38
Standard BioTools
LAB
$271M
$41.9M 0.72%
5,755,753
+1,370,490
+31% +$8.61M
CVS icon
39
CVS Health
CVS
$121B
$41.3M 0.71%
523,796
+515,686
+6,359% +$41.7M
CVX icon
40
Chevron
CVX
$427B
$38.5M 0.66%
326,816
-116,351
-26% -$12.7M
AGN
41
DELISTED
Allergan plc
AGN
$32.1M 0.55%
152,673
-137,120
-47% -$28.4M
BNY
42
Bank of New York Mellon
BNY
$105B
$32M 0.55%
674,960
-58,506
-8% -$2.64M
RVTY icon
43
Revvity
RVTY
$15.6B
$31.6M 0.54%
605,702
+597,302
+7,111% +$31.2M
GE icon
44
GE Aerospace
GE
$319B
$30.6M 0.53%
202,339
-35,790
-15% -$5.2M
PHG icon
45
Philips
PHG
$24.3B
$29.3M 0.5%
1,292,985
+1,873
+0.1% +$40.8K
GOLF icon
46
Acushnet Holdings
GOLF
$4.85B
$29M 0.5%
+1,471,848
New +$28.3M
ORCL icon
47
Oracle
ORCL
$404B
$28.3M 0.49%
735,682
+39,777
+6% +$1.56M
CWEN icon
48
Clearway Energy Class C
CWEN
$6.14B
$28.2M 0.48%
1,784,942
-17,789
-1% -$278K
AXP icon
49
American Express
AXP
$219B
$27.3M 0.47%
368,397
+360,945
+4,844% +$25M
BHI
50
DELISTED
Baker Hughes
BHI
$25.7M 0.44%
396,315
+392,315
+9,808% +$23.3M
1
2
3 4 5

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.49B AUM 32.81% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $1.49B AUM 26.43% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.49B AUM 28.35% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.49B AUM 21.79% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TIA
Tandem Investment Advisors Charleston, South Carolina $1.49B AUM 12.33% 1-Year Est. Return
MM
Main Management San Francisco, California $1.49B AUM 22.28% 1-Year Est. Return
WA
WBH Advisory Baltimore, Maryland $1.49B AUM 20.41% 1-Year Est. Return

Levin Capital Strategies's Q4 2016 Portfolio in Review

As of Q4 2016, Levin Capital Strategies held 370 positions worth $5.82B, down 14% from $6.8B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Levin Capital Strategies withdrew a net $270M in Q4 2016, closing 67 positions and reducing 141 holdings. Its most notable exit was Univar Solutions Inc., an estimated $25.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 31% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Levin Capital Strategies opened a new position in Athene Holding Ltd. Class A Common Shares worth $68.8M.

  • Levin Capital Strategies's largest Q4 2016 buy was Athene Holding Ltd. Class A Common Shares: 1,433,996 shares worth $68.8M.
  • Levin Capital Strategies added most to Thermo Fisher Scientific in Q4 2016, an estimated $98.8M increase.
  • Levin Capital Strategies's biggest Q4 2016 reduction was Gilead Sciences, cutting an estimated $162M.
  • Levin Capital Strategies fully exited Univar Solutions Inc. in Q4 2016, selling an estimated $25.1M.
  • Levin Capital Strategies's ten largest holdings make up 39% of its $5.82B portfolio in Q4 2016.
  • Levin Capital Strategies opened 37 new positions and closed 67 in Q4 2016.
  • Levin Capital Strategies's portfolio value fell 14% quarter-over-quarter to $5.82B.

Based on Levin Capital Strategies's 13F filing for Q4 2016, filed 14 Feb 2017.